Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
presidentDonald TrumpOn Monday signed a stimulating executive order setting a 30-day deadline for the dragmakers to choose the cost of the prescribed US medications what the government will pay.
Order calls to the health department, ledRobert F. Kennedy Jr.With new broker prices for drugs for next month. If deals are not reached, Kennedy will be stamed to develop a new rule binding the price US pay for drugs in other countries.
“Let us adapt,” Trump said to a Monday at the Morning Press Conference. “We all pay the same. We will pay what Europe will pay.”
It is unclear what – if there is an impact on the order of the President of the Republican in millions of Americans with health health insurance. The federal government has the most power shop power that it pays for drugs covered by Medicare and Medicaid.
Trump new – but not sure – the storage of drug prices, only hours after the Republican led homeits new plan to cut $ 880 billion from Medicaid.
Spent on taxpayersHundreds of billions of dollarsIn prescription drugs, injectable, fertilize and other medications each year by Medicare, consisting of almost 70 million older people. Medicaid, which provides almost free health care to almost 80 million poor and disabled people in the US tooSpend tens of billion dollarseach year for drugs.
The main drug drayings say that Trump’s order is not good for patients
The country’s pharmaceutisical lobby represents leading drug drivers in the US, promptly pushed against Trump’s order, which is called a “bad deal” for American patients. The druggradmar has long argued that any threats to their profit can affect the research they do to develop new drugs.
“Importing foreign prices from socialist countries can be a bad deal for American patients and workers,” said President J. UBL in Phrma, as a statement. “It means less treatments and healing and risking hundreds of billions of member companies planned to invest in America.”
The so-called “most preferred country” method of medicare drug pricing because he first attempted to implement it in his first term. He signedA similar Executive OrderIn the last weeks of his Presidency, calling for the US only to pay only a lower price to other drugs – such as injectable or injections provided to infusions – managed by the doctor’s office.
That narrow executive order facing hurdles, withA court orderblocking the rule from going under President Joe Biden administration. The pharmaceutical industry argues that 2020 Trump’s 2020 tests will provide foreign governments to the “upper hand” to decide the amount of US drugs
Trump says other countries to blame
Trump is repeated by the pharmaceutical companies, instead of blaming other countries for high priced Americans, in a wide language of the White House on Monday. The President is set to Kennedy, Center for Medicare and Medicaid Services OZ, commissioner commissioner Commander and National Instations of Health Director Jay Bhattacharya.
However, he threatened companies with a federal investigation into their habits and opening the US market to carry several countries.
“The pharmaceutical companies that make the most of their income from America,” Trump said. “That’s not a good thing.”
Trump played the weekend announcement, boasting a post that his plan could save “trillions of dollars.”
But on Monday, the White House has not offered for how much money administration is expected to save.
The leading health department leaders will meet drug company executives for the next 30 days to offer new drugs based on other countries, OZ said on Monday.
Americans may not see immediate storage
Americans may not see the relief of increasing drug costs easily due to the order, Rachel Sachs said, an expert in Washington University’s health law.
“That’s how the plan is to ask for volunteer manufacturers to lower their prices at some point, without knowing,” says Sachs. “If they do not lower their prices at the desired point, HHS will take other actions with a high timeline, which some can be drug prices.”
The Health Department has the most authority to change drug prices covered by Medicare and Medicaid because it can set regulations. However, the agency’s power to do is limited. Congress approved by 2022A new lawThat allows Medicare to negotiate the price of this payment for a certain prescribed prescription that begins with 2026. Before the law, Medicare pays the drug company. Drug companies who have not succeeded in implementing law enforcement.
The price of millions of Americans are covered by insurancepay for medicationsmore difficult for maneuvering agency.
The frequent US countries in drug prices, compared to other large and rich nations, a problem that has long been deprived of Congress.
Trump has entered his first term accusing pharmaceutical companies “lose execution” and complain that other countries that drug prices have benefited from Americans.
Trump said he ‘do the right thing’
Ahead of the Announcement, Trump Puffed Up His Rhetoric Toward The Industry Again on Social Media, Writing That “Pharmaceutical / Drug Companies Would Say, and That All of These Costs Werever, Borne by the ‘Suckers’ of America, Alone. “
Referring to heavy drug lobbies, he said that campaign contributions “can do wonders, but not with me, and not the Republican Party.”
“We will do the right thing,” he wrote.
Many pharmaceutical companies get the land in the stock market on Monday morning. particleA company producing $ 64.2 billion last year with the help of the cancer treatment of the keytruda, jumped by 3.9%. Descent of harm Pfizewhich is targeted $ 63.6 billion income of 2024, rose 2.5% while Gilead sciences Rose 5.8%.
This story originally shown Fortune.com
Source link
